Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
8.80
-0.08 (-0.90%)
Jul 10, 2025, 4:00 PM - Market closed
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $1.25 billion as of July 11, 2025. Its market cap has decreased by -64.75% in one year.
Market Cap
1.25B
Enterprise Value
591.15M
1-Year Change
-64.75%
Ranking
Category
Stock Price
$8.80
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $1.25B, an increase of 57.46%. That is a compound annual growth rate of 9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 1.25B | -48.06% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 708.92B |
| Johnson & Johnson | 375.37B |
| AbbVie | 339.03B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 277.72B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.85B |
| AstraZeneca | 216.19B |